The global organ preservation market is projected to reach USD 384 million by 2028 from USD 207 million in 2019, at a CAGR of 6.5%. The growth of the organ preservation market is mainly driven by the increasing incidence of multi-organ failure, the growing geriatric population, the rising number of organ transplants and organ donors, and increasing initiatives to encourage organ donations. However, the high cost of organ transplantations and religious concerns in specific geographies are expected to limit market growth to a certain extent.

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2021–2028. The major factors driving the growth of the Asia Pacific market include favorable government initiatives, increased awareness in people and increased organ donations. Intensified public education, mobilization, and advancements in organ transplant technologies have improved the donation rate in China. In India, Rapid improvements in the country’s healthcare infrastructure have supported market growth while encouraging medical tourism. The willingness to donate organs in Japan has led to the improvement in organ donation despite religious issues. Other countries have initiative reimbursement programs, paired organ donation scheme with other patients within the country and across countries, have improved the growth of this market drastically.

The increasing number of organ transplantation procedures across the globe and rising cases of multiple organ failure are the major factors propelling the market growth. According to a report published by the Health Resources & Services Administration in 2019, around 36,528 organ transplantation were performed in the U.S. in 2018, and around 95.00% of adults in the country support organ donation. It also reported that around 17,553 donors were recorded in 2018 of which 10,722 were deceased donors and 6,831 were living donors.

By Solution

---

• University of Wisconsin

---

• Custodiol HTK

---

• Perfadex

---

• Other Solutions

---

By Technique

---

• Static Cold Storage

---

• Hypothermic Machine Perfusion

---

• Normothermic Machine Perfusion

---

By Organ type

---

• Kidneys

---

• Liver

---

• Lungs

---

• Heart

---

• Other Organs

---

Market Players

---

• Bristol-Myers Squibb

---

• Xvivo Perfusion AB

---

• Essential Pharmaceuticals LLC

---

• Franz Kohler Chemie GmbH

---

• BioLife Solutions, Inc.

---

• Bristol-Myers Squibb

---

• Claris Lifesciences Limited

---

• Lifeline Scientific

---

• ToleroTech, Inc.

---

• 21st Century Medicine

---

• CryoLife, Inc

---

By Region

---

• North America

  ---

  ---

  • U.S.

  ---

  • Canada

  ---

  • Mexico

  ---

  ---

---

• Europe

  ---

  ---

  • Germany

  ---

  • U.K.

  ---

  • France

  ---

  • Italy

  ---

  • Spain

  ---

  • Sweden

  ---

  • Russia

  ---

  • Switzerland

  ---

  • Netherlands

  ---

  • Rest Of Europe

  ---

  ---

---

• Asia-Pacific

  ---

  ---

  • Japan

  ---

  • China

  ---

  • India

  ---

  • Indonesia

  ---

  • Australia

  ---

  • Vietnam

  ---

  • New Zealand

  ---

  • Philippines

  ---

  • South Korea

  ---

  • Taiwan

  ---

  • Singapore

  ---

  • Rest Of Asia-Pacific

  ---

  ---

---

• South America

  ---

  ---

  • Brazil

  ---

  • Argentina

  ---

  • Rest Of South America

  ---

  ---

---

• Middle East & Africa

  ---

  ---

  • South Africa

  ---

  • U.A.E.

  ---

  • Saudi Arabia

  ---

  • Rest Of Middle East And Africa

  ---

  ---

---